Published in Am J Pathol on January 01, 2002
LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev (2008) 3.46
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9. Cancer Res (2009) 1.38
The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res (2009) 1.37
Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim Biophys Acta (2009) 1.23
Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res (2010) 1.16
LRP-1 promotes cancer cell invasion by supporting ERK and inhibiting JNK signaling pathways. PLoS One (2010) 1.10
ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol Biol Cell (2004) 1.08
Plasminogen activator inhibitor-1 regulates myoendothelial junction formation. Circ Res (2010) 1.05
LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities. Mol Cell Biol (2008) 1.04
SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair. Arch Dermatol Res (2008) 1.02
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1. PPAR Res (2009) 1.01
Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing. Am J Pathol (2006) 1.00
SERPINE1 (PAI-1) is a prominent member of the early G0 --> G1 transition "wound repair" transcriptome in p53 mutant human keratinocytes. J Invest Dermatol (2007) 0.97
Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycle. Bioessays (2007) 0.92
Plasminogen activator inhibitor 1 protects fibrosarcoma cells from etoposide-induced apoptosis through activation of the PI3K/Akt cell survival pathway. Neoplasia (2008) 0.91
LRP-1: a checkpoint for the extracellular matrix proteolysis. Biomed Res Int (2013) 0.90
PAI-1 and functional blockade of SNAI1 in breast cancer cell migration. Breast Cancer Res (2008) 0.88
Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell lines. PLoS One (2007) 0.87
LRP-1--CD44, a new cell surface complex regulating tumor cell adhesion. Mol Cell Biol (2012) 0.87
Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors. Toxicology (2008) 0.85
C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer. Breast Cancer Res (2003) 0.83
Matrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signaling. PLoS One (2012) 0.83
Variation in innate immunity genes and risk of multiple myeloma. Hematol Oncol (2011) 0.81
Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes. Mol Biol Cell (2013) 0.80
Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features. Adv Pharmacol (2013) 0.80
Accumulation of uPA-PAI-1 complexes inside the tumour cells is associated with axillary nodal invasion in progesterone-receptor-positive early breast cancer. Br J Cancer (2003) 0.79
The Matricellular Receptor LRP1 Forms an Interface for Signaling and Endocytosis in Modulation of the Extracellular Tumor Environment. Front Pharmacol (2015) 0.78
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment. Clin Exp Metastasis (2017) 0.75
Cell migration: a physically integrated molecular process. Cell (1996) 23.49
Breast tumor cell lines from pleural effusions. J Natl Cancer Inst (1974) 5.39
The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer (1997) 5.01
Regulation of integrin function by the urokinase receptor. Science (1996) 3.56
The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin. Nature (1996) 3.34
Leukocyte polarization in cell migration and immune interactions. EMBO J (1999) 3.08
Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis. Mol Biol Cell (1999) 2.61
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med (1998) 2.54
Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell (1986) 2.38
Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol (1999) 2.35
Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem (1999) 2.32
Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol (1996) 2.21
Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J Cell Biol (1999) 2.11
Urokinase receptor and integrin partnership: coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol (2000) 2.09
The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest (1994) 1.82
Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J Exp Med (1997) 1.65
Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol (1994) 1.65
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes. EMBO J (1997) 1.64
Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J Biol Chem (1993) 1.50
Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest (1997) 1.49
Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein. J Biol Chem (1998) 1.42
Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity. J Biol Chem (2000) 1.38
Cytoskeletal rearrangement during migration and activation of T lymphocytes. Trends Cell Biol (1999) 1.28
Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness. Clin Exp Metastasis (1996) 1.27
Examination of the function of RANTES, MIP-1alpha, and MIP-1beta following interaction with heparin-like glycosaminoglycans. J Biol Chem (2000) 1.24
Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. Thromb Res (1998) 1.20
The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J Biol Chem (1995) 1.17
Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas. Int J Cancer (1996) 1.16
Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp Cell Res (1997) 1.14
Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood (1999) 1.12
Receptor-mediated endocytosis of CC-chemokines. J Biol Chem (1997) 1.12
Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J Biol Chem (1995) 1.09
Cellular localization of urokinase-type plasminogen activator, its inhibitors, and their mRNAs in breast cancer tissues. J Pathol (1997) 1.08
CC chemokine receptor-3 undergoes prolonged ligand-induced internalization. J Biol Chem (1999) 1.05
Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin. J Biol Chem (1990) 1.04
Substrates for astrocytoma invasion. Neurosurgery (1995) 1.04
The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis. J Biol Chem (2000) 1.02
Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis. J Biol Chem (1997) 1.01
Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br J Cancer (1991) 0.99
Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system. Int J Cancer (1997) 0.98
Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implications. Biol Chem Hoppe Seyler (1995) 0.96
Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol (1987) 0.93
Extracellular matrix remodeling by metalloproteinases and plasminogen activators. Kidney Int Suppl (1995) 0.92
Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Exp Cell Res (2000) 0.92
In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg (1995) 0.91
Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading. J Cell Sci (1997) 0.89
Very low density lipoprotein receptor from mammary gland and mammary epithelial cell lines binds and mediates endocytosis of M(r) 40,000 receptor associated protein. FEBS Lett (1994) 0.88
Consensus conference on the classification of ductal carcinoma in situ. Hum Pathol (1997) 0.88
Cell surface expression of urokinase receptor in normal mammary epithelial cells and breast cancer cell lines. Anticancer Res (1999) 0.87
Regulation of urokinase receptor transcription by Ras- and Rho-family GTPases. Biochem Biophys Res Commun (2000) 0.84
Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780. Clin Exp Metastasis (1997) 0.81
Real-time analysis of integrin-mediated chemotactic migration of T lymphocytes within 3-D extracellular matrix-like gels. J Immunol Methods (1999) 0.81
Urokinase receptor mediates mechanical force transfer across the cell surface. Am J Physiol (1995) 0.81
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med (2007) 7.87
Autocrine and paracrine angiopoietin 1/Tie-2 signaling promotes muscle satellite cell self-renewal. Cell Stem Cell (2009) 2.53
Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol (2003) 2.19
Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell (2007) 2.16
Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol (2002) 1.96
Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway. Genes Dev (2008) 1.73
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. Am J Hum Genet (2013) 1.70
Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. Am J Pathol (2004) 1.46
Neurofibromatosis 1-associated neuropathies: a reappraisal. Brain (2004) 1.40
Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells (2011) 1.38
Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One (2009) 1.36
Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci (2006) 1.34
MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas. Mod Pathol (2002) 1.34
Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol (2009) 1.31
Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol (2005) 1.21
Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve (2005) 1.19
Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol (2006) 1.18
Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum (2010) 1.13
c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal (2010) 1.12
Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA. Haematologica (2012) 1.11
Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med (2013) 1.09
ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol Biol Cell (2004) 1.08
Invasion of human glioma biopsy specimens in cultures of rodent brain slices: a quantitative analysis. J Neurosurg (2002) 1.06
Flow cytometric immunophenotyping of cerebrospinal fluid. Curr Protoc Cytom (2008) 1.03
Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction. J Inorg Biochem (2009) 1.03
Chronic fatigue syndrome in patients with macrophagic myofasciitis. Arthritis Rheum (2003) 1.02
Developmentally regulated expression of VGLUT3 during early post-natal life. Neuropharmacology (2005) 1.01
Dual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healing. Am J Pathol (2006) 1.00
Peptides derived from the onconeural HuD protein can elicit cytotoxic responses in HHD mouse and human. J Neuroimmunol (2003) 0.97
RPA is an initiation factor for human chromosomal DNA replication. Nucleic Acids Res (2003) 0.96
The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. Haematologica (2010) 0.96
Identification of productive inhibitor binding orientation in fatty acid amide hydrolase (FAAH) by QM/MM mechanistic modelling. Chem Commun (Camb) (2007) 0.95
Astroglial permissivity for neuritic outgrowth in neuron-astrocyte cocultures depends on regulation of laminin bioavailability. Glia (2002) 0.94
Distinct populations of human PCNA are required for initiation of chromosomal DNA replication and concurrent DNA repair. Exp Cell Res (2005) 0.93
Antiangiogenic therapy against experimental glioblastoma using genetically engineered cells producing interferon-alpha, angiostatin, or endostatin. Hum Gene Ther (2003) 0.90
Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics. Am J Surg Pathol (2012) 0.89
Hyperstructures, genome analysis and I-cells. Acta Biotheor (2002) 0.89
A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy. Muscle Nerve (2012) 0.89
Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle. PLoS One (2012) 0.89
PAI-1 and functional blockade of SNAI1 in breast cancer cell migration. Breast Cancer Res (2008) 0.88
Relationship between pressure-volume curve and markers for collagen turn-over in early acute respiratory distress syndrome. Intensive Care Med (2006) 0.88
Effects of the proteasome inhibitor ritonavir on glioma growth in vitro and in vivo. Mol Cancer Ther (2004) 0.88
Dermatomyositis, lobar panniculitis and inflammatory myopathy with abundant macrophages. Neuromuscul Disord (2006) 0.87
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy. J Neuropathol Exp Neurol (2010) 0.87
Inflammatory myopathy with abundant macrophages (IMAM): a condition sharing similarities with cytophagic histiocytic panniculitis and distinct from macrophagic myofasciitis. J Neuropathol Exp Neurol (2003) 0.87
Long-term follow-up of cognitive dysfunction in patients with aluminum hydroxide-induced macrophagic myofasciitis (MMF). J Inorg Biochem (2011) 0.87
Catalysis in glycine N-methyltransferase: testing the electrostatic stabilization and compression hypothesis. Biochemistry (2006) 0.86
Type 2 myotonic dystrophy can be predicted by the combination of type 2 muscle fiber central nucleation and scattered atrophy. J Neuropathol Exp Neurol (2008) 0.86
Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol (2007) 0.85
Mutant IDH1 inhibits PI3K/Akt signaling in human glioma. Cancer (2014) 0.84
In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression. Am J Pathol (2005) 0.84
T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade. Nephrol Dial Transplant (2010) 0.83
Matrix-bound PAI-1 supports cell blebbing via RhoA/ROCK1 signaling. PLoS One (2012) 0.83
Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model. Arthritis Rheum (2012) 0.82
Toxoplasmic myositis as a presenting manifestation of idiopathic CD4 lymphocytopenia. Muscle Nerve (2003) 0.82
AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background. Neuromuscul Disord (2006) 0.82
Whole microvascular unit deletions in dermatomyositis. Ann Rheum Dis (2012) 0.82
Dual level of interactions between calcineurin and PKC-epsilon in cardiomyocyte stretch. Cardiovasc Res (2006) 0.81
HLA-DRB1*01 and macrophagic myofasciitis. Arthritis Rheum (2002) 0.80
Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study. J Inorg Biochem (2013) 0.80
Blood neutrophil bactericidal activity against methicillin-resistant and methicillin-sensitive Staphylococcus aureus during cardiac surgery. Shock (2005) 0.78
Mechanisms of protein circular dichroism: insights from computational modeling. Adv Protein Chem Struct Biol (2010) 0.78
Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol Commun (2014) 0.78
Delayed cardiomyopathy in dystrophin deficient mdx mice relies on intrinsic glutathione resource. Am J Pathol (2010) 0.78
Incorporation of manganese complexes into xylanase: new artificial metalloenzymes for enantioselective epoxidation. Chembiochem (2011) 0.78
Dual effects of exercise in dysferlinopathy. Am J Pathol (2013) 0.78
Individual contributions of the aromatic chromophores to the near-UV Circular Dichroism in class A beta-lactamases: A comparative computational analysis. Biophys Chem (2010) 0.77
Intramolecular hydrogen bonding as a determinant of the inhibitory potency of N-unsubstituted imidazole derivatives towards mammalian hemoproteins. Metallomics (2008) 0.76
IL-12 secreting dendritic cells are required for optimum activation of human secondary lymphoid tissue T cells. J Immunother (2002) 0.76
Various strategies for obtaining artificial hemoproteins: from "hemoabzymes" to "hemozymes". Biochimie (2009) 0.76
[The PAI-1 swing: microenvironment and cancer cell migration]. C R Biol (2006) 0.75
Safety and immunogenicity of hepatitis B vaccine regimens in adults with HIV-1. JAMA (2011) 0.75
[Intrasinusal bone marrow lymphoid infiltration]. Ann Pathol (2002) 0.75
[Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?]. Bull Acad Natl Med (2014) 0.75
July 2003: 62-year-old female with progressive muscular weakness. Brain Pathol (2004) 0.75
Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case report. Medicine (Baltimore) (2017) 0.75
Juvenile dermatomyositis. Handb Clin Neurol (2013) 0.75
Modelling molecular interactions with game networks' theory. C R Biol (2006) 0.75
A 42-year-old man with a densely vascular spinal mass. Brain Pathol (2007) 0.75
Luminescent Probes for Sensitive Detection of pH Changes in Live Cells through Two Near-Infrared Luminescence Channels. ACS Sens (2017) 0.75
[Macrophages regulate skeletal muscle regeneration]. Med Sci (Paris) (2007) 0.75
Neocarzinostatin-based hybrid biocatalysts for oxidation reactions. Dalton Trans (2014) 0.75
Structural and computational enzymology: bringing experiments and computations together. Adv Protein Chem Struct Biol (2012) 0.75
A unique 1-amino-1-cyclopropane carboxylate cupric-cryptate hosting sodium. Dalton Trans (2014) 0.75